381 related articles for article (PubMed ID: 19181251)
41. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
42. Single or multi-channel vaginal cuff high-dose-rate brachytherapy: Is replanning necessary prior to each fraction?
Zhou J; Prisciandaro J; Lee C; Schipper M; Eisbruch A; Jolly S
Pract Radiat Oncol; 2014; 4(1):20-6. PubMed ID: 24621419
[TBL] [Abstract][Full Text] [Related]
43. [Optimization of dose distribution in combined irradiation of uterine cervix cancer with gamma-ray cesium-137 and X-9 MeV].
Lewocki M
Ann Acad Med Stetin; 1996; 42():199-222. PubMed ID: 9199121
[TBL] [Abstract][Full Text] [Related]
44. Comparision of four different dose specification methods for high-dose-rate intracavitary radiation for treatment of cervical cancer.
Mai J; Erickson B; Rownd J; Gillin M
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1131-41. PubMed ID: 11704338
[TBL] [Abstract][Full Text] [Related]
45. Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.
Westerveld H; Pötter R; Berger D; Dankulchai P; Dörr W; Sora MC; Pötter-Lang S; Kirisits C
Radiother Oncol; 2013 Apr; 107(1):99-105. PubMed ID: 23639578
[TBL] [Abstract][Full Text] [Related]
46. Practice patterns of radiotherapy in cervical cancer among member groups of the Gynecologic Cancer Intergroup (GCIG).
Gaffney DK; Du Bois A; Narayan K; Reed N; Toita T; Pignata S; Blake P; Portelance L; Sadoyze A; Pötter R; Colombo A; Randall M; Mirza MR; Trimble EL
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):485-90. PubMed ID: 17336465
[TBL] [Abstract][Full Text] [Related]
47. Does the apex optimization line matter for single-channel vaginal cylinder brachytherapy planning?
Kim Y; Cabel K; Sun W
J Appl Clin Med Phys; 2018 Jul; 19(4):307-312. PubMed ID: 29766643
[TBL] [Abstract][Full Text] [Related]
48. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer.
Chong I; Hoskin PJ
Brachytherapy; 2008; 7(2):195-9. PubMed ID: 18358790
[TBL] [Abstract][Full Text] [Related]
49. Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience.
Tan LT; Coles CE; Hart C; Tait E
Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):175-82. PubMed ID: 19101130
[TBL] [Abstract][Full Text] [Related]
50. Impact of vaginal cylinder diameter on outcomes following brachytherapy for early stage endometrial cancer.
Qian JM; Stahl JM; Young MR; Ratner E; Damast S
J Gynecol Oncol; 2017 Nov; 28(6):e84. PubMed ID: 29027402
[TBL] [Abstract][Full Text] [Related]
51. Individual fraction optimization vs. first fraction optimization for multichannel applicator vaginal cuff high-dose-rate brachytherapy.
Symon Z; Menhel J; Alezra D; Pfeffer MR
Brachytherapy; 2006; 5(4):211-5. PubMed ID: 17118311
[TBL] [Abstract][Full Text] [Related]
52. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy.
Georg P; Kirisits C; Goldner G; Dörr W; Hammer J; Pötzi R; Berger D; Dimopoulos J; Georg D; Pötter R
Radiother Oncol; 2009 May; 91(2):173-80. PubMed ID: 19243846
[TBL] [Abstract][Full Text] [Related]
53. Retrospective dosimetric comparison of low-dose-rate and pulsed-dose-rate intracavitary brachytherapy using a tandem and mini-ovoids.
Mourtada F; Gifford KA; Berner PA; Horton JL; Price MJ; Lawyer AA; Eifel PJ
Med Dosim; 2007; 32(3):181-7. PubMed ID: 17707197
[TBL] [Abstract][Full Text] [Related]
54. Dosimetric effects of air pockets around high-dose rate brachytherapy vaginal cylinders.
Richardson S; Palaniswaamy G; Grigsby PW
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):276-9. PubMed ID: 20395068
[TBL] [Abstract][Full Text] [Related]
55. Surface optimization technique for MammoSite breast brachytherapy applicator.
Kirk M; Hsi WC; Dickler A; Chu J; Dowlatshahi K; Francescatti D; Nguyen C
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):366-72. PubMed ID: 15890576
[TBL] [Abstract][Full Text] [Related]
56. Characteristics of miniature electronic brachytherapy x-ray sources based on TG-43U1 formalism using Monte Carlo simulation techniques.
Safigholi H; Faghihi R; Jashni SK; Meigooni AS
Med Phys; 2012 Apr; 39(4):1971-9. PubMed ID: 22482618
[TBL] [Abstract][Full Text] [Related]
57. Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry.
Tanderup K; Christensen JJ; Granfeldt J; Lindegaard JC
Radiother Oncol; 2006 Apr; 79(1):87-93. PubMed ID: 16546281
[TBL] [Abstract][Full Text] [Related]
58. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium.
Nag S; Erickson B; Parikh S; Gupta N; Varia M; Glasgow G
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):779-90. PubMed ID: 11020575
[TBL] [Abstract][Full Text] [Related]
59. [Dose calculations for local irradiation of endometrial carcinoma].
Martin M; Kühnle H; Frischkorn R
Strahlenther Onkol; 1986 May; 162(5):308-15. PubMed ID: 3754985
[TBL] [Abstract][Full Text] [Related]
60. Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer.
Suzuki O; Yoshioka Y; Isohashi F; Morimoto M; Kotsuma T; Kawaguchi Y; Konishi K; Nakamura S; Shiomi H; Inoue T
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1329-34. PubMed ID: 18439763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
